Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
PT2.12.04 Osimertinib + Savolitinib in EGFRm Advanced NSCLC With MET Overexp And/Or Amp Post-Progression on Osimertinib: SAVANNAH PROs
2025
0 citations
Journal Article
Field-Weighted Citation Impact:
0.00
·
Yonsei University
J.S. Lee
·
Seoul National University Bundang Hospital
Isamu Okamoto
·
Kyushu University Hospital
J Shimizu
·
Aichi Cancer Center
Lorenzo Livi
·
Azienda Ospedaliero-Universitaria Careggi
G. de Castro
·
Instituto do Câncer do Estado de São Paulo
Yu Jung Kim
·
Seoul National University Bundang Hospital
P. Bironzo
·
University of Turin
J.C.-H. Yang
·
National Taiwan University Hospital
Lecia V. Sequist
·
Massachusetts General Hospital
Mark E. Haskins
·
AstraZeneca (Spain)
I. Igwegbe
·
AstraZeneca (Netherlands)
Lei Shi
·
Institute for Patient- and Family-Centered Care
Wei Xu
·
AstraZeneca (Spain)
M-J. Ahn
·
Sungkyunkwan University
PT2.12.04 Osimertinib + Savolitinib in EGFRm Advanced NSCLC With MET Overexp And/Or Amp Post-Progression on Osimertinib: SAVANNAH PROs | Researchclopedia